Anti-GPC3 scFv h(b2c-CD3ζ) CART, pCDCAR1

"The vector of anti-GPC3 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human GPC3. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-GPC3 antibody linked to CD3-zeta and b2c signaling domains. And the vector product was designed for the treatment of hepatocellular carcinoma (HCC). https://www.creative-biolabs.com/car-t/pcdcar1-gpc3-h-b2c%CE%B6-t-322.htm"